The influence of a dominating centre on a quantitative systematic review of granisetron for preventing postoperative nausea and vomiting
Open Access
- 1 July 2001
- journal article
- research article
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 45 (6) , 659-670
- https://doi.org/10.1034/j.1399-6576.2001.045006659.x
Abstract
Background: We performed a meta‐analysis on granisetron in the prevention of postoperative nausea and vomiting (PONV) and further investigated whether total results and the dose–response characteristics may be significantly affected by a single centre.Methods: Systematically searched randomised controlled trials (RCT) using granisetron for the prevention of PONV after general anaesthesia were included in the analysis. The pooled relative risks (RR) and numbers needed to treat (NNT) with their corresponding 95%‐confidence intervals (CI) were calculated. For all centres, one dominating centre and other centres pooled, comparisons were performed according to all doses, low dose (≤20 μg/kg) and high dose (>20 μg/kg) granisetron.Results: A total of 27 RCT with 2938 patients were included in the analysis. RR (CI) to suffer from PONV with granisetron when all comparisons were considered was 0.46 (0.39–0.54), 0.7 (0.6–0.81) and 0.34 (0.28–0.41) for all doses, low and high dose, respectively. RR of the dominating centre (1867 patients) were significantly better compared to the remaining centres (1071 patients), with 0.41 (0.34–0.49) and 0.60 (0.49–0.73), respectively. In the dominating centre low dose granisetron was ineffective with a RR of 0.84 (0.68–1.04), while high dose granisetron led to a strong decrease with a RR of 0.30 (0.26–0.36). In contrast, the RR of other centres pooled for low and high dose granisetron were comparable with 0.62 (0.49–0.79) and 0.56 (0.42–0.75), respectively.Conclusions: Overall results and dose–response characteristics of meta‐analyses may be significantly altered by one dominating centre. Further, if data of a dominating centre do not appear to be valid for other centres, it may seem advisable to either exclude them from the analysis or to perform sub‐group analyses so that results without the data from the dominating centre are available.Keywords
This publication has 51 references indexed in Scilit:
- Reported Data on Granisetron and Postoperative Nausea and Vomiting by Fujii et al. Are Incredibly Nice!Anesthesia & Analgesia, 2000
- Granisetron reduces post-operative vomiting in children: a dose-ranging studyEuropean Journal of Anaesthesiology, 1999
- Prevention of nausea and vomiting in female patients undergoing breast surgery: A comparison with granisetron, droperidol, metoclopramide and placeboActa Anaesthesiologica Scandinavica, 1998
- Optimal Dose of Granisetron for Prophylaxis Against Postoperative Emesis After Gynecological SurgeryAnesthesia & Analgesia, 1997
- Antiemetic effects of granisetron on postoperative nausea and vomiting in patients with and without motion sicknessCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1996
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Prevention of postoperative nausea and vomiting with granisetron: a randomized, double-blind comparison with droperidolCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1995
- Optimal anti-emetic dose of granisetron for preventing post-operative nausea and vomitingCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1994
- An Assessment of Clinically Useful Measures of the Consequences of TreatmentNew England Journal of Medicine, 1988
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986